{"transactions":[{"id":1103403,"issuer":{"id":7842,"kind":"organization","name":"Genvor Inc"},"owners":[{"id":78215,"kind":"person","name":"Yates Clayton Clopton","position":1,"cik":"0002000242","reported_name":"Yates Clayton Clopton","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:32:01.000Z","date":"2025-05-08","kind":"grant","planned":true,"acquired":true,"shares":400000,"price":0.25,"value":100000.0,"ownership":{"direct":false,"nature":"ACT Holdings, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Conversion of $100,000 in accrued payables due to Dr. Yates at $0.25/share. The issuance of the 400K shares to Clayton in consideration of his conversion of $100K in accrued payables, pursuant to Dr. Yates's restructured compensation package, which permits Dr. Yates to convert amounts due to him into common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Yates is a manager of, and may therefore be deemed to be the beneficial owner of shares held in the name of, ACT Holdings, LLC."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001903596-25-000319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359625000319/ownership.xml","form_type":"4"}}]}